Core Scientific, Inc.
NASDAQCore Scientific heads into this week with a sharp contradiction at its core — the Street is aggressively lifting targets after a strong earnings beat, yet short sellers are actually adding rather than running. The analyst signal is the standout this week. Following the Q1 print, target prices moved sharply higher across the board. Jefferies raised its target to $37 — a 54% premium…
Snapshot as of 21 May 2026
Core Scientific heads into this week with a sharp contradiction at its core — the Street is aggressively lifting targets after a strong earnings beat, yet short sellers are actually adding rather than running. The…
Core Scientific heads into its Q1 earnings report on May 7 with the stock in the middle of a powerful short-covering rally — and with executives cashing out at every step of the way up. The insider-selling pattern is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CORZ — free to start on ORTEX.
Sign up for free →Open CORZ on ORTEX